Skip to main content
رجوع
Watch Compare

Electromedical Technologies, Inc

جودة البيانات: 100%
EMED
OTC Manufacturing Measuring & Analyzing Instruments
KWD 0.00
KWD 0.00 (0.00%)
القيمة السوقية: 667,858.0
السعر
KWD 0.00
القيمة السوقية
667,858.0
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Negative free cash flow of -131,211.0
Capital efficient — spends only 0.00% of revenue on capex

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)17.30%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-190.83%
Op. Margin-114.92%

الأمان

Debt / Equity
N/A
Current Ratio0.07
Interest Coverage-4.38

التقييم

PE (TTM)
-0.40
أعلى من متوسط القطاع (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.4 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % -190.8 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17.30% Revenue Growth (3Y) 35.19%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 879,484.0 Net Income (TTM) -1.68 M
ROE N/A ROA -272.07%
Gross Margin 78.71% Operating Margin -114.92%
Net Margin -190.83% Free Cash Flow (TTM) -131,211.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.07
Interest Coverage -4.38 Asset Turnover 1.43
Working Capital -4.05 M Tangible Book Value -4.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.40 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -19.65%
Market Cap 667,858.0 Enterprise Value 633,049.0
Per Share
EPS (Diluted TTM) 0.01 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 7.82%
SBC-Adj. FCF -141,711 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2023 FY2022 FY2020 FY2021
Revenue 1.35 M 1.15 M 737,958.0 907,362.0
Net Income -2.64 M -3.47 M -3.87 M -8.48 M
EPS (Diluted) 0.00 -0.03 — -0.24
Gross Profit 1.05 M 888,641.0 543,574.0 708,128.0
Operating Income -2.06 M -1.60 M -3.17 M -3.80 M
EBITDA — — — —
R&D Expenses 231,434.0 92,299.0 31,600.0 215,320.0
SG&A Expenses 3.11 M 2.49 M 3.71 M 4.51 M
D&A 4,557.0 21,875.0 21,875.0 21,875.0
Interest Expense 893,155.0 791,072.0 769,591.0 3.31 M
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2023 FY2022 FY2020 FY2021
Total Assets 748,383.0 1.35 M 1.42 M 1.40 M
Total Liabilities 3.62 M 3.57 M 2.74 M 2.12 M
Shareholders' Equity -2.87 M -2.22 M -1.32 M -722,503.0
Total Debt 150,000.0 671,525.0 732,266.0 702,780.0
Cash & Equivalents 87,704.0 368,425.0 264,913.0 383,170.0
Current Assets 449,185.0 647,802.0 647,179.0 674,767.0
Current Liabilities 3.36 M 2.92 M 2.02 M 1.44 M